| All patients | Non-AKI patients | AKI patients | P- value |
---|---|---|---|---|
 | (n = 2,940) | (n = 2,531; 86%) | (n = 409; 14%) |  |
Intraoperative data | ||||
Isolated CABG | 32.1% (945) | 33.6% (851) | 23.0% (94) | 0.005 |
Isolated valve surgery | 51.6% (1,518) | 51.8% (1,311) | 51.6% (207) | 0.85 |
CABG + valve surgery | 6.9% (203) | 6.2% (158) | 11.0% (45) | <0.001 |
Other cardiac surgery | 9.4% (274) | 8.4% (211) | 15.4% (63) | <0.001 |
Emergent surgery | 5.1% (149) | 3.9% (99) | 12.2% (50) | <0.001 |
Number of bypass | 2.3 ±0.9 | 2.3 ± 0.8 | 2.2 ± 0.9 | 0.68 |
ACC time (minutes) | 73 ± 29 | 72 ± 28 | 87 ± 37 | <0.001 |
CPB time (minutes) | 113 ± 41 | 109 ± 37 | 135 ± 55 | <0.001 |
Postoperative data | ||||
Ventilation time (hours) | 50 ± 127 | 36 ± 96 | 139 ± 229 | <0.001 |
PaO2/FiO2 ratio on admission | 331 ± 98 | 334 ± 96 | 315 ± 106 | 0.001 |
PaO2/FiO2 ratio 12 h after admission | 311 ± 89 | 316 ± 87 | 278 ± 93 | <0.001 |
PaO2/FiO2 ratio 24 h after admission | 307 ± 77 | 314 ± 72 | 270 ± 90 | <0.001 |
Reintubation | 1.1% (31) | 0.8% (21) | 2.5% (10) | 0.001 |
Tracheostomy | 1.3% (38) | 0.8% (19) | 4.7% (19) | 0.001 |
Need of vasoactive drugs (hours) | 103 ± 141 | 82 ± 110 | 195 ± 210 | <0.001 |
LCOS | 41.6% (1,223) | 36.3% (920) | 74.1% (303) | <0.001 |
PMI | 11.8% (346) | 10% (252) | 23% (94) | <0.001 |
IABP support | 7.8% (230) | 6.1% (155) | 18.3% (75) | <0.001 |
Atrial fibrilation | 39.4% (1,158) | 36.1% (913) | 59.9% (245) | <0.001 |
AL on admission (mmol · L-1) | 2.3 ± 1.4 | 2.2 ± 1.2 | 3.1 ± 2.3 | <0.001 |
AL 24 h after admission (mmol · L-1) | 1.9 ± 1.0 | 1.8 ± 0.7 | 2.6 ± 1.9 | <0.001 |
sCr peak after surgery (mmol · L-1) | 114.3 ± 80.8 | 99.0 ± 62.0 | 205.0 ± 113.0 | <0.001 |
Albumin 48 h after surgery (g · L-1) | 28.2 ± 3.7 | 28.4 ± 3.6 | 26.5 ± 4.1 | <0.001 |
Hemorrhage-related re-exploration | 3.5% (103) | 2.6% (66) | 9.0% (37) | <0.001 |
Pericardial tamponade | 0.7% (22) | 0.4% (11) | 2.7% (11) | <0.001 |
Drainage loss first 12 h (mL) | 393 ± 301 | 377 ± 275 | 496 ± 414 | <0.001 |
Major bleeding | 3.6% (109) | 2.6% (66) | 10.5% (43) | <0.001 |
Re-exploration | 1.6% (48) | 0.8% (21) | 5.1% (27) | <0.001 |
Need for blood products (units) | 1.6 ± 3.0 | 1.4 ± 2.5 | 3.3 ± 4.6 | <0.001 |
Stroke | 1.4% (42) | 0.9% (24) | 4.4% (18) | <0.001 |
Septicemia | 6.6% (195) | 4.0% (102) | 22.7% (93) | <0.001 |
SAPS II | 24.2 ± 9.6 | 22.8 ± 8.3 | 32.3 ± 12.8 | <0.001 |
SAPS III | 39.9 ± 10.4 | 38.6 ± 9.4 | 48.4 ± 12.3 | <0.001 |
APACHE II | 12.3 ± 4.6 | 11.6 ± 4.0 | 16.1 ± 6.3 | <0.001 |
APACHE III | 49.9 ± 18.5 | 47.0 ± 15.0 | 67.0 ± 24.0 | <0.001 |
Mean Pre-ICU stay (days) | 7.0 ± 13.0 | 6.7 ± 8.6 | 8.7 ± 28.8 | 0.15 |
Mean ICU stay (days) | 7.5 ± 11.0 | 6.2 ± 7.7 | 15.2 ± 20.3 | <0.001 |
Mean hospital stay (days) | 24.6 ± 22.5 | 22.8 ± 15.7 | 36.1 ± 44.5 | <0.001 |
In-hospital mortality | 6.0% (177) | 2.4% (60) | 28.6% (117) | <0.001 |